Exercise and Doxorubicin Modify Markers of Iron Overload and Cardiolipin Deficiency in Cardiac Mitochondria

Doxorubicin (DOX) is a chemotherapeutic agent highly effective at limiting cancer progression. Despite the efficacy of this anticancer drug, the clinical use of DOX is limited due to cardiotoxicity. The cardiac mitochondria are implicated as the primary target of DOX, resulting in inactivation of el...

Full description

Bibliographic Details
Main Authors: Boeno, F.P (Author), Bomkamp, M.P (Author), Doerr, V. (Author), Dowllah, I.M (Author), Montalvo, R.N (Author), Moritz, C.E.J (Author), Nguyen, B.L (Author), Smuder, A.J (Author)
Format: Article
Language:English
Published: MDPI 2023
Subjects:
rat
Online Access:View Fulltext in Publisher
View in Scopus